E.M. Guerra
Impact in
-
- Ovarian cancer diagnosis and treatment
-
- PARP inhibition in cancer therapy
Papers in
- Oncology 6
- PARP inhibition in cancer therapy 3
- HER2/EGFR in Cancer Research 2
- Cancer Treatment and Pharmacology 1
-
- Ovarian cancer diagnosis and treatment 5
- Co-authors
- Antonio González-Martı́n (4 shared papers)Andrés Redondo (3 shared papers)Maria-Pilar Barretina-Ginesta (2 shared papers)María Jesús Rubio (2 shared papers)Luís Manso (2 shared papers)José Alejandro Pérez Fidalgo (2 shared papers)Yolanda García García (2 shared papers)Cristina Martín-Lorente (1 shared paper)
- Journals
- Annals of Oncology (3 papers)Clinical & Translational Oncology (2 papers)Multiple Sclerosis and Related Disorders (1 paper)ESMO Open (1 paper)
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
E.M. Guerra
8 papers receiving 77 citations
Peers
Comparison fields: 5 of 34
- Reproductive Medicine 36
- Oncology 43
- Obstetrics and Gynecology 8
- Cancer Research 11
- Structural Biology 1
Countries citing papers authored by E.M. Guerra
This map shows the geographic impact of E.M. Guerra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.M. Guerra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.M. Guerra more than expected).
Fields of papers citing papers by E.M. Guerra
This network shows the impact of papers produced by E.M. Guerra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.M. Guerra. The network helps show where E.M. Guerra may publish in the future.
Co-authors
The 25 scholars most cited alongside E.M. Guerra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 29 | |
| 2 | 2021 | 23 | |
| 3 | 2016 | 17 | |
| 4 | 2020 | 3 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 1 | |
| 7 | 2019 | 1 | |
| 8 | 2012 | 1 |
About E.M. Guerra
E.M. Guerra is a scholar working on Oncology, Reproductive Medicine, Pulmonary and Respiratory Medicine, Immunology and Cancer Research, having authored 8 papers that have together received 77 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (5 papers), PARP inhibition in cancer therapy (3 papers), HER2/EGFR in Cancer Research (2 papers), Cancer Treatment and Pharmacology (1 paper), Cancer Genomics and Diagnostics (1 paper), Breast Cancer Treatment Studies (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Toxin Mechanisms and Immunotoxins (1 paper). The work is most often cited by research in Reproductive Medicine (36 citations), Oncology (43 citations), Obstetrics and Gynecology (8 citations), Cancer Research (11 citations) and Structural Biology (1 citation). E.M. Guerra has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Antonio González-Martı́n, Andrés Redondo, Maria-Pilar Barretina-Ginesta, María Jesús Rubio, Luís Manso, José Alejandro Pérez Fidalgo, Yolanda García García, Cristina Martín-Lorente, Jerónimo Martínez-García and Ana Santaballa. Their work appears in journals such as Annals of Oncology, Clinical & Translational Oncology, Multiple Sclerosis and Related Disorders and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.